BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11372804)

  • 1. Abuse of combinations of carisoprodol and tramadol.
    Reeves RR; Liberto V
    South Med J; 2001 May; 94(5):512-4. PubMed ID: 11372804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carisoprodol (soma): abuse potential and physician unawareness.
    Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
    J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible dangerous interaction of oxycontin and carisoprodol.
    Reeves RR; Mack JE
    Am Fam Physician; 2003 Jun; 67(11):2273. PubMed ID: 12800958
    [No Abstract]   [Full Text] [Related]  

  • 4. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tramadol (Ultram) concentrations in death investigation and impaired driving cases and their significance.
    Clarkson JE; Lacy JM; Fligner CL; Thiersch N; Howard J; Harruff RC; Logan BK
    J Forensic Sci; 2004 Sep; 49(5):1101-5. PubMed ID: 15461118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prescription shopping of addictive drugs in Norway].
    Winther RB; Bramness JG
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):517-20. PubMed ID: 19282887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carisoprodol abuse in Mississippi.
    Reeves RR; Henderson RH; Ladner ME
    J Miss State Med Assoc; 2007 Dec; 48(12):363-5. PubMed ID: 19292137
    [No Abstract]   [Full Text] [Related]  

  • 8. Basic pharmacology relevant to drug abuse assessment: tramadol as example.
    Raffa RB
    J Clin Pharm Ther; 2008 Apr; 33(2):101-8. PubMed ID: 18315774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse of skeletal muscle relaxants.
    Elder NC
    Am Fam Physician; 1991 Oct; 44(4):1223-6. PubMed ID: 1927837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carisoprodol, meprobamate, and driving impairment.
    Logan BK; Case GA; Gordon AM
    J Forensic Sci; 2000 May; 45(3):619-23. PubMed ID: 10855968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal unintentional intoxications with tramadol during 1995-2005.
    Tjäderborn M; Jönsson AK; Hägg S; Ahlner J
    Forensic Sci Int; 2007 Dec; 173(2-3):107-11. PubMed ID: 17350197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential.
    Bramness JG; Furu K; Skurtveit S; Engeland A
    Clin Pharmacol Ther; 2012 Mar; 91(3):438-41. PubMed ID: 22318620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004.
    Cicero TJ; Inciardi JA; Adams EH; Geller A; Senay EC; Woody GE; Muñoz A
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):851-9. PubMed ID: 15892169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abuse of Carisoprodol].
    Lindberg N; Lauerma H
    Duodecim; 1996; 112(2):109-11. PubMed ID: 10590614
    [No Abstract]   [Full Text] [Related]  

  • 16. Current trends in tramadol-related fatalities, Tehran, Iran 2005-2008.
    Iravani FS; Akhgari M; Jokar F; Bahmanabadi L
    Subst Use Misuse; 2010 Nov; 45(13):2162-71. PubMed ID: 20394504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain.
    Adams EH; Breiner S; Cicero TJ; Geller A; Inciardi JA; Schnoll SH; Senay EC; Woody GE
    J Pain Symptom Manage; 2006 May; 31(5):465-76. PubMed ID: 16716877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Skurtveit S; Furu K; Kaasa S; Borchgrevink PC
    Eur J Pain; 2009 Oct; 13(9):949-53. PubMed ID: 19095476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment due to intake of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J
    Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carisoprodol: update on abuse potential and legal status.
    Reeves RR; Burke RS; Kose S
    South Med J; 2012 Nov; 105(11):619-23. PubMed ID: 23128807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.